Nycomed In-licensing is a strategic core element at global, regional and local levels. We focus on licensing as a path to continued growth and retention of the companys position as one of the 28 largest pharmaceutical companies in the world. We have a vision to be the preferred partner.
All phases of a products lifecycle
It is essential for Nycomed to manage all phases of a products lifecycle
- In-licensing
- Conclusion of cooperation
- Strategic alliance
- Good relations to the suppliers
Therefore we can – closely aligned with regional and local conditions – bring optimal conditions in play and hence achieve better profits and benefits for all parties involved.
Read more about:
What we are looking for
Nycomed is looking for products within several therapeutic areas
Partnering with Nycomed
Nycomed offer our partners a platform with direct access to the markets in which Nycomed is one of the leading pharmaceutical companies and an important stakeholder.
Regional and local focus
Locally as well as regionally, we focus on oppertunities for in-licensing within late stage development projects (faseII) or new chemical substances with value adding features and characteristics. Furthermore we have an interest in generics which are commercially substainable in a local market.